Redmile Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$221K	Hold	82,955	–	–	0.02%	48
2025 Q1	$666K	Hold	82,955	–	–	0.06%	55
2024 Q4	$801K	Hold	82,955	–	–	0.06%	59
2024 Q3	$1.54M	Hold	82,955	–	–	0.09%	60
2024 Q2	$1.38M	Hold	82,955	–	–	0.08%	58
2024 Q1	$1.44M	Hold	82,955	–	–	0.05%	73
2023 Q4	$1.3M	Hold	82,955	–	–	0.05%	63
2023 Q3	$4.1M	Hold	82,955	–	–	0.2%	54
2023 Q2	$6.49M	Hold	82,955	–	–	0.25%	55
2023 Q1	$7.52M	Hold	82,955	–	–	0.33%	56
2022 Q4	$9.79M	Hold	82,955	–	–	0.4%	48
2022 Q3	$15.1M	Buy	82,955 +47,156	+132%	+$8.56M	0.58%	46
2022 Q2	$3.21M	Hold	35,799	–	–	0.12%	63
2022 Q1	$5.56M	Hold	35,799	–	–	0.17%	60
2021 Q4	$10.7M	Sell	35,799 -588	-2%	-$175K	0.24%	57
2021 Q3	$21M	Sell	36,387 -32,487	-47%	-$18.7M	0.37%	54
2021 Q2	$31.3M	Sell	68,874 -15,630	-18%	-$7.1M	0.46%	54
2021 Q1	$45.5M	Sell	84,504 -16,609	-16%	-$8.94M	0.64%	49
2020 Q4	$89.4M	Sell	101,113 -339	-0.3%	-$300K	1.08%	30
2020 Q3	$64.2M	Buy	+101,452	New	+$64.2M	1.18%	30